1. Uff C, Frith D, Harrison C, Powell M, Kitchen N. Sir Victor Horsley's 19th century operations at the National Hospital for Neurology and Neurosurgery, Queen Square. J Neurosurg. 2011; 114:534–42.
2. Stevanovic A, Rossaint R, Veldeman M, Bilotta F, Coburn M. Anaesthesia management for awake craniotomy: systematic review and meta-analysis. PLoS One. 2016; 11:e0156448.
3. Gerritsen JKW, Arends L, Klimek M, Dirven CMF, Vincent AJE. Impact of intraoperative stimulation mapping on high-grade glioma surgery outcome: a meta-analysis. Acta Neurochir (Wien). 2019; 161:99–107.
4. Eseonu CI, Rincon-Torroella J, ReFaey K, Lee YM, Nangiana J, Vivas-Buitrago T, et al. Awake craniotomy vs craniotomy under general anesthesia for perirolandic gliomas: evaluating perioperative complications and extent of resection. Neurosurgery. 2017; 81:481–9.
5. Meng L, Berger MS, Gelb AW. The potential benefits of awake craniotomy for brain tumor resection: an anesthesiologist's perspective. J Neurosurg Anesthesiol. 2015; 27:310–7.
6. Meng L, McDonagh DL, Berger MS, Gelb AW. Anesthesia for awake craniotomy: a how-to guide for the occasional practitioner. Can J Anaesth. 2017; 64:517–29.
7. Hervey-Jumper SL, Li J, Lau D, Molinaro AM, Perry DW, Meng L, et al. Awake craniotomy to maximize glioma resection: methods and technical nuances over a 27-year period. J Neurosurg. 2015; 123:325–39.
8. Rajan S, Cata JP, Nada E, Weil R, Pal R, Avitsian R. Asleep-awake-asleep craniotomy: a comparison with general anesthesia for resection of supratentorial tumors. J Clin Neurosci. 2013; 20:1068–73.
9. Bajwa SJ, Anand S, Kaur G. Anesthesia and cancer recurrences: the current knowledge and evidence. J Cancer Res Ther. 2015; 11:528–34.
10. Kim R. Effects of surgery and anesthetic choice on immunosuppression and cancer recurrence. J Transl Med. 2018; 16:8.
11. Meserve JR, Kaye AD, Prabhakar A, Urman RD. The role of analgesics in cancer propagation. Best Pract Res Clin Anaesthesiol. 2014; 28:139–51.
12. Brown T, Shah AH, Bregy A, Shah NH, Thambuswamy M, Barbarite E, et al. Awake craniotomy for brain tumor resection: the rule rather than the exception? J Neurosurg Anesthesiol. 2013; 25:240–7.
13. Richardson AM, McCarthy DJ, Sandhu J, Mayrand R, Guerrero C, Rosenberg C, et al. Predictors of successful discharge of patients on postoperative day 1 after craniotomy for brain tumor. World Neurosurg. 2019; 126:e869–77.
14. Ruis C, Wajer IH, Robe P, van Zandvoort M. Anxiety in the preoperative phase of awake brain tumor surgery. Clin Neurol Neurosurg. 2017; 157:7–10.
15. Potters JW, Klimek M. Awake craniotomy: improving the patient's experience. Curr Opin Anaesthesiol. 2015; 28:511–6.
16. Skucas AP, Artru AA. Anesthetic complications of awake craniotomies for epilepsy surgery. Anesth Analg. 2006; 102:882–7.
17. Eseonu CI, ReFaey K, Garcia O, John A, Quiñones-Hinojosa A, Tripathi P. Awake craniotomy anesthesia: a comparison of the monitored anesthesia care and asleep-awake-asleep techniques. World Neurosurg. 2017; 104:679–86.
18. Dilmen OK, Akcil EF, Oguz A, Vehid H, Tunali Y. Comparison of conscious sedation and asleep-awake-asleep techniques for awake craniotomy. J Clin Neurosci. 2017; 35:30–4.
19. Kulikov A, Lubnin A. Anesthesia for awake craniotomy. Curr Opin Anaesthesiol. 2018; 31:506–10.
20. Sewell D, Smith M. Awake craniotomy: anesthetic considerations based on outcome evidence. Curr Opin Anaesthesiol. 2019; 32:546–52.
21. Lobo F, Beiras A. Propofol and remifentanil effect-site concentrations estimated by pharmacokinetic simulation and bispectral index monitoring during craniotomy with intraoperative awakening for brain tumor resection. J Neurosurg Anesthesiol. 2007; 19:183–9.
22. Soehle M, Wolf CF, Priston MJ, Neuloh G, Bien CG, Hoeft A, et al. Propofol pharmacodynamics and bispectral index during key moments of awake craniotomy. J Neurosurg Anesthesiol. 2018; 30:32–8.
23. Lin N, Vutskits L, Bebawy JF, Gelb AW. Perspectives on dexmedetomidine use for neurosurgical patients. J Neurosurg Anesthesiol. 2019; 31:366–77.
24. Goettel N, Bharadwaj S, Venkatraghavan L, Mehta J, Bernstein M, Manninen PH. Dexmedetomidine vs propofol-remifentanil conscious sedation for awake craniotomy: a prospective randomized controlled trial. Br J Anaesth. 2016; 116:811–21.
25. McAuliffe N, Nicholson S, Rigamonti A, Hare GMT, Cusimano M, Garavaglia M, et al. Awake craniotomy using dexmedetomidine and scalp blocks: a retrospective cohort study. Can J Anaesth. 2018; 65:1129–37.
26. Garavaglia MM, Das S, Cusimano MD, Crescini C, Mazer CD, Hare GM, et al. Anesthetic approach to high-risk patients and prolonged awake craniotomy using dexmedetomidine and scalp block. J Neurosurg Anesthesiol. 2014; 26:226–33.
27. Rylova A, Maze M. Protecting the brain with xenon anesthesia for neurosurgical procedures. J Neurosurg Anesthesiol. 2019; 31:18–29.
28. Potters JW, Klimek M. Local anesthetics for brain tumor resection: current perspectives. Local Reg Anesth. 2018; 11:1–8.
29. Fontaine D, Almairac F. Pain during awake craniotomy for brain tumor resection. Incidence, causes, consequences and management. Neurochirurgie. 2017; 63:204–7.
30. Cormack J, Karna S. Macroglossia during awake craniotomy: a near miss. J Neurosurg Anesthesiol. 2018; 30:383–4.
31. Lee WK, Kim H, Bae MI, Choi SH, Min KT. Accidental intracerebral injection and seizure during scalp nerve blocks for awake craniotomy in a previously craniotomized patient- a case report. Korean J Anesthesiol. 2018; 71:483–5.
32. Spena G, Schucht P, Seidel K, Rutten GJ, Freyschlag CF, D'Agata F, et al. Brain tumors in eloquent areas: a European multicenter survey of intraoperative mapping techniques, intraoperative seizures occurrence, and antiepileptic drug prophylaxis. Neurosurg Rev. 2017; 40:287–98.
33. Spena G, Roca E, Guerrini F, Panciani PP, Stanzani L, Salmaggi A, et al. Risk factors for intraoperative stimulation-related seizures during awake surgery: an analysis of 109 consecutive patients. J Neurooncol. 2019; 145:295–300.
34. Chandra V, Rock AK, Opalak C, Stary JM, Sima AP, Carr M, et al. A systematic review of perioperative seizure prophylaxis during brain tumor resection: the case for a multicenter randomized clinical trial. Neurosurg Focus. 2017; 43:E18.
35. Pourzitaki C, Tsaousi G, Apostolidou E, Karakoulas K, Kouvelas D, Amaniti E. Efficacy and safety of prophylactic levetiracetam in supratentorial brain tumour surgery: a systematic review and meta-analysis. Br J Clin Pharmacol. 2016; 82:315–25.
36. Abdulrauf SI, Vuong P, Patel R, Sampath R, Ashour AM, Germany LM, et al. "Awake" clipping of cerebral aneurysms: report of initial series. J Neurosurg. 2017; 127:311–8.
37. Chan DYC, Chan DTM, Zhu CXL, Kan PKY, Ng AY, Hsieh YPS, et al. Awake craniotomy for excision of arteriovenous malformations? A qualitative comparison study with stereotactic radiosurgery. J Clin Neurosci. 2018; 51:52–6.
38. Duffau H. Is non-awake surgery for supratentorial adult low-grade glioma treatment still feasible? Neurosurg Rev. 2018; 41:133–9.
39. Ruis C. Monitoring cognition during awake brain surgery in adults: a systematic review. J Clin Exp Neuropsychol. 2018; 40:1081–104.